Literature DB >> 34962616

Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment.

Ke Shi1,2, Yao Liu1, Qun Zhang1, Chong-Ping Ran1, Jie Hou1,2, Yi Zhang1, Xian-Bo Wang3.   

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, is a major public health issue. The epidemic is unlikely to be contained until the global launch of safe and effective vaccines that could prevent serious illnesses and provide herd immunity. Although most patients have mild flu-like symptoms, some develop severe illnesses accompanied by multiple organ dysfunction. The identification of pathophysiology and early warning biomarkers of a severe type of COVID-19 contribute to the treatment and prevention of serious complications. Here, we review the pathophysiology, early warning indicators, and effective treatment of Chinese and Western Medicine for patients with a severe type of COVID-19.
© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine; coronavirus disease 2019; indicators; pathogenesis; treatment

Mesh:

Year:  2021        PMID: 34962616      PMCID: PMC8713541          DOI: 10.1007/s11655-021-3313-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment
  124 in total

Review 1.  Evolving functions of endothelial cells in inflammation.

Authors:  Jordan S Pober; William C Sessa
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

2.  Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.

Authors:  Céline Louapre; Nicolas Collongues; Bruno Stankoff; Claire Giannesini; Caroline Papeix; Caroline Bensa; Romain Deschamps; Alain Créange; Abir Wahab; Jean Pelletier; Olivier Heinzlef; Pierre Labauge; Laurent Guilloton; Guido Ahle; Mathilde Goudot; Kevin Bigaut; David-Axel Laplaud; Sandra Vukusic; Catherine Lubetzki; Jérôme De Sèze; Fayçal Derouiche; Ayman Tourbah; Guillaume Mathey; Marie Théaudin; François Sellal; Marie-Hélène Dugay; Helene Zéphir; Patrick Vermersch; Françoise Durand-Dubief; Romain Françoise; Géraldine Androdias-Condemine; Julie Pique; Pékès Codjia; Caroline Tilikete; Véronique Marcaud; Christine Lebrun-Frenay; Mikael Cohen; Aurelian Ungureanu; Elisabeth Maillart; Ysoline Beigneux; Thomas Roux; Jean-Christophe Corvol; Amandine Bordet; Yanica Mathieu; Frédérique Le Breton; Dalia Dimitri Boulos; Olivier Gout; Antoine Guéguen; Antoine Moulignier; Marine Boudot; Audrey Chardain; Sarah Coulette; Eric Manchon; Samar S. Ayache; Thibault Moreau; Pierre-Yves Garcia; Deiva Kumaran; Giovanni Castelnovo; Eric Thouvenot; Julien Poupart; Arnaud Kwiatkowski; Gilles Defer; Nathalie Derache; Pierre Branger; Damien Biotti; Jonathan Ciron; Christine Clerc; Mathieu Vaillant; Laurent Magy; Alexis Montcuquet; Philippe Kerschen; Marc Coustans; Anne-Marie Guennoc; Bruno Brochet; Jean-Christophe Ouallet; Aurélie Ruet; Cécile Dulau; Sandrine Wiertlewski; Eric Berger; Dan Buch; Bertrand Bourre; Maud Pallix-Guiot; Aude Maurousset; Bertrand Audoin; Audrey Rico; Adil Maarouf; Gilles Edan; Jérémie Papassin; Dorothée Videt
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection.

Authors:  Yong Zeng; Bo Zhang; Xufeng Zhang; Cunjian Yi
Journal:  Chin Med       Date:  2020-05-14       Impact factor: 5.455

5.  Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes.

Authors:  Mario Adán Moreno-Eutimio; Constantino López-Macías; Rodolfo Pastelin-Palacios
Journal:  Microbes Infect       Date:  2020-04-30       Impact factor: 2.700

6.  Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

Authors:  Ivan Fn Hung; Kelvin Kw To; Cheuk-Kwong Lee; Kar-Lung Lee; Kenny Chan; Wing-Wah Yan; Raymond Liu; Chi-Leung Watt; Wai-Ming Chan; Kang-Yiu Lai; Chi-Kwan Koo; Tom Buckley; Fu-Loi Chow; Kwan-Keung Wong; Hok-Sum Chan; Chi-Keung Ching; Bone Sf Tang; Candy Cy Lau; Iris Ws Li; Shao-Haei Liu; Kwok-Hung Chan; Che-Kit Lin; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

7.  Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.

Authors:  Ling Lin; Lianfeng Lu; Wei Cao; Taisheng Li
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 8.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

Authors:  Mahmoud Gheblawi; Kaiming Wang; Anissa Viveiros; Quynh Nguyen; Jiu-Chang Zhong; Anthony J Turner; Mohan K Raizada; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2020-04-08       Impact factor: 17.367

Review 9.  The case of complement activation in COVID-19 multiorgan impact.

Authors:  Marina Noris; Ariela Benigni; Giuseppe Remuzzi
Journal:  Kidney Int       Date:  2020-05-24       Impact factor: 10.612

10.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

View more
  3 in total

Review 1.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

2.  Comparison between clinical characteristics and laboratory findings among patients with complicated and noncomplicated SARS-CoV-2 infection: A single-center experience from Shebin Al-Kom, Egypt.

Authors:  Walaa A Fadda; Manal A Al-Batanony; Reham E E Aboukhalil; Heba F Khader; Osamah Al Rugaie
Journal:  Immun Inflamm Dis       Date:  2022-08

3.  Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies.

Authors:  Mohammad Halimi; Parvindokht Bararpour
Journal:  J Mol Model       Date:  2022-08-29       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.